IC50: 8.6 nM (EZH2); 62 nM (EZH1)[1].
DC50: 140 nM (EZH2 in MDA-MB-453 cells)[1]
MS8815 is a selective enhancer of zeste homolog 2 (EZH2)
[1]. Brandon Dale, et al. Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2. ACS Pharmacol Transl Sci. 2022 Jun 24;5(7):491-507.
















